Results 201 to 210 of about 53,940 (250)

Vasopressin

Seminars in Respiratory and Critical Care Medicine, 2004
Vasopressin is a hormone that is essential for both osmotic and cardiovascular homeostasis. A deficiency of vasopressin exists in some shock states and replacement of physiological levels of vasopressin can restore vascular tone. Vasopressin is therefore emerging as a rational therapy for vasodilatory shock.
Cheryl L, Holmes, James A, Russell
openaire   +2 more sources

Vasopressin Antagonists

New England Journal of Medicine, 2015
SCOPUS: le.j ; info:eu-repo/semantics ...
Vandergheynst, Frederic, Gankam Kengne, Fabrice, Decaux, Guy   +2 more
openaire   +4 more sources

Vasopressin antagonists

Cellular and Molecular Life Sciences, 2006
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a variety of water-retaining diseases and cardiovascular diseases, including heart failure, hyponatraemia, hypertension, renal diseases, syndrome of inappropriate antidiuretic hormone secretion, cirrhosis and ocular hypertension.
Lemmens, Rosa, Kamyar, Majid-Reza
openaire   +2 more sources

Vasopressin-Receptor Antagonists

Future Cardiology, 2010
Despite a crucial role in body fluid homeostasis, elevated vasopressin levels can also be pathological in conditions such as congestive heart failure, liver cirrhosis and the syndrome of inappropriate antidiuretic hormone secretion. The result of elevated vasopressin is renal water retention and hyponatremia, a low serum sodium concentration ...
Hoorn, Ewout, Zietse, R.
openaire   +2 more sources

Effect of exogenous vasopressin on vasopressin release

American Journal of Physiology-Endocrinology and Metabolism, 1984
To characterize the influence of extracellular volume status on vasopressin pharmacokinetics, eleven young (aged 19-31 yr) and four old (aged 62-80 yr) subjects received bolus injections of 1 mU/kg Pitressin or synthetic arginine vasopressin following 6 days of sodium depletion (10 meq Na/day) or sodium loading (250 meq Na/day).
P A, Engel, J W, Rowe, K L, Minaker, G L, Robertson   +3 more
openaire   +2 more sources

Vasopressin and vasopressin receptors in brain edema

2020
Vasopressin is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Secretion of vasopressin is followed by activation of its receptors V1a, V1b, and V2 throughout the body. Each receptor type is responsible for a specific function of vasopressin.
Emil, Zeynalov, Susan M, Jones, J Paul, Elliott   +2 more
openaire   +2 more sources

Vasopressin Receptors

Trends in Endocrinology & Metabolism, 2000
The biological effects of arginine vasopressin (AVP) are mediated by three receptor subtypes: the V1a and V1b receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with Gs. Isolation of the cDNAs encoding the V1a and V1b receptor subtypes explained the tissue variability of V1 antagonist ...
openaire   +2 more sources

Vasopressin and Vasopressin Antagonists in Heart Failure

2017
Despite the introduction of multiple new pharmacological agents over the past three decades in the field of heart failure (HF), overall prognosis remains poor. Hyponatremia is prevalent in HF patients and has been suggested as a contributor to poor response to standard therapy.
Julie K, Vishram-Nielsen, Finn, Gustafsson   +1 more
openaire   +2 more sources

Vasopressin Tachyphylaxis

Journal of Pharmaceutical Sciences, 1964
P N, PATIL, J W, NELSON, A, TYE
openaire   +2 more sources

Vasopressin infusion

Gastroenterology, 1980
M, Ufberg, L, Rigberg, C, Brooks
openaire   +2 more sources